These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1428799)

  • 1. Veralipride-induced tardive dystonia in a patient with bipolar psychosis.
    Gabellini AS; Pezzoli A; De Massis P; Sacquegna T
    Ital J Neurol Sci; 1992 Oct; 13(7):621-3. PubMed ID: 1428799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulpiride-induced tardive dystonia.
    Miller LG; Jankovic J
    Mov Disord; 1990; 5(1):83-4. PubMed ID: 1967484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Extrapyramidal adverse effects of veralipride (Agreal), a drug used to treat hot flushes: a propos of 17 cases].
    Masmoudi K; Gras-Champel V; Lemaire-Hurtel AS; Masson H; Munier A; Geslin JM; Andréjak M
    Rev Med Interne; 2005 Jun; 26(6):453-7. PubMed ID: 15936474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive dyskinesia after long-term veralipride treatment.
    Raja M; Azzoni A
    J Neuropsychiatry Clin Neurosci; 2005; 17(2):252-3. PubMed ID: 15939983
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and hormonal effects of long-term veralipride treatment in post-menopausal women.
    Verbeke K; Dhont M; Vandekerckhove D
    Maturitas; 1988 Oct; 10(3):225-30. PubMed ID: 3185294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extrapyramidal disorders induced by veralipride (Agreal). Apropos of 5 cases].
    Masmoudi K; Decocq G; Chetaille E; Rosa A; Mizon JP; Andréjak M
    Therapie; 1995; 50(5):451-4. PubMed ID: 8571284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Respiratory dyskinesia induced by veralipride].
    Marta-Moreno E; Gracia-Naya M; Marzo-Sola ME
    Rev Neurol; 1997 Feb; 25(138):245-7. PubMed ID: 9147748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amisulpride-induced tardive dystonia: a case report.
    Guriz O; Ekinci AE; Orsel S; Ekinci O
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):412-3. PubMed ID: 19944732
    [No Abstract]   [Full Text] [Related]  

  • 9. Tardive dystonia associated with low-dose of amisulpride: a case report.
    Sevincok L; Balci V; Akyildiz U
    J Clin Psychopharmacol; 2008 Oct; 28(5):573-4. PubMed ID: 18794659
    [No Abstract]   [Full Text] [Related]  

  • 10. [Parkinson syndrome induced by veralipride].
    Franchignoni FP; Tesio L
    Minerva Ginecol; 1995 Jun; 47(6):277-9. PubMed ID: 7478098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-hormonal therapy for menopausal disorders: results of a multicentric double-blind trial (author's transl)].
    Linquette M; Rivière J; Vague J
    Sem Hop; 1980 Oct; 56(37-38):1445-8. PubMed ID: 6254159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Veralipride in the treatment of hot flushes in the menopause].
    Pasetto N; Piccione E; Baschieri L
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):163-5. PubMed ID: 3922035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of the action of a new molecule, veralipride, on menopausal psychofunctional disorders (author's transl)].
    Delanian L
    Sem Hop; 1980 Oct; 56(37-38):1468-70. PubMed ID: 6254163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of menopausal hot flushes with a nonhormonal medication, veralipride].
    Marzolf G; Eberst B; Aerts A; Lecornu C; Mark J; Gandar R
    Sem Hop; 1982 Nov; 58(41):2382-4. PubMed ID: 6297023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of veralipride.
    De Leo V; Morgante G; Musacchio MC; Faldini E; Delia A; Petraglia F
    Expert Opin Drug Saf; 2006 Sep; 5(5):695-701. PubMed ID: 16907659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Veralipride and menopause].
    Laffargue F; Viala JL; Durand G
    Sem Hop; 1983 Sep; 59(29-30):2127-30. PubMed ID: 6312585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Consensus conference of the Mexican Association for the Study of Climateric on veralipride prescription for patients with vasomotor symptoms].
    Basavilvazo-Rodríguez A; Bravo-Rodríguez LM; Carranza-Lira S; Celis-González C; Hernández Marín I; Hernández-Valencia M; López Navarro ME; Alvarado Maldonado Jde D; Armando Montaño J; Moreno Avellán AJ; Vázquez G
    Ginecol Obstet Mex; 2012 Jul; 80(7):467-72. PubMed ID: 22916640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and clinical and biological tolerance of long-term veralipride administration. Apropos of 74 case reports].
    Dargent D; Dumont M; Malinas Y
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):171-3. PubMed ID: 3992114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of veralipride in menopausal sudden flushes (author's transl)].
    Wesel S; L'Hermite M
    Sem Hop; 1980 Oct; 56(37-38):1465-7. PubMed ID: 6254162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Veralipride: alternative antidopaminergic treatment for menopausal symptoms.
    David A; Don R; Tajchner G; Weissglas L
    Am J Obstet Gynecol; 1988 May; 158(5):1107-15. PubMed ID: 2967034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.